Treatment of adrenocortical carcinoma;Le traitement du cortico-surrenalome malin

Presse Medicale

Volumn 26, Issue 18, 1997, Pages 880-884

  Andres E ^a   Grunenberger, F ^a   Kurtz, J E ^a   Goichot, B ^a   Dufour, P ^a   Schlienger, J L ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; INTERFERON; KETOCONAZOLE; METYRAPONE; MIFEPRISTONE; MITOTANE; SURAMIN;

ADRENAL CORTEX CARCINOMA; CANCER REGRESSION; HUMAN; PROGNOSIS; REVIEW; ADJUVANT CHEMOTHERAPY; ADRENAL CORTEX TUMOR; PALLIATIVE THERAPY;

ADRENAL CORTEX NEOPLASMS; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; HUMANS; PALLIATIVE CARE;

EID: 0030946835     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. e eds. De Vita VT Jr, Hellmann S, Rosenberg SA eds. JB Lippincott, Philadelphia 1993 : 1333-435.
2. ère ed. Steg E, Eschwege F, eds Flammarion-Sciences France 1991 : 99-134.
3. Luton JP, Cerdas S, Billaud L et al. Clinical features of adrenal carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990 ; 322:1195-201.
4. Cohn K, Gottesman N, Brennan MF. Adrenal carcinoma. Surgery 1986 ; 100:1170-7.
5. Henley DJ, Van Heerden JA, Grant CS, Carney JA, Carpentier PC. Adrenal cortical carcinoma - a continuing challenge. Surgery 1983 ; 94:926-31.
6. Icard P, Chapuis Y, Andreassian B, Bepuand A, Proye C. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine. Surgery 1992 ; 112:972-9.
7. Linos DA, Vassipopoulos P, Papadimitriou J et al. The surgical management of adrenal cortical carcinoma. Int Surg 1986 ; 71:104-6.
8. Appelquist P, Kostianinen S. Multiple thoracotomy combined with chemotherapy in metastatic adrenal cortical carcinoma: a case report and review of the literature. J Surg Oncol 1983 ; 24:1-4.
9. Potter DA, Strott CA, Javadpour N et al. Prolonged survival following six pulmonary resections for metastatic adrenal cortical carcinoma: a case report. J Surg Oncol 1984 ; 25:273-7.
10. Pommier RF, Brennan MF. An eleven year experience with adrenocortical carcinoma. Surgery 1992 ; 112:963-70.
11. Gutierrez ML, Crooke ST. Mitotane (o,p'DDD) in inoperable adrenocortical carcinoma. Cancer Treat Rev 1980 ; 7:49-55.
12. Schteingart DE, Motazedi A, Noonan RA, Thompson NW. Treatment of adrenal carcinomas. Arch Surg 1982 ; 117: 1142-6.
13. Nader S, Hickey RC, Sellin RV. Adrenal cortical carcinoma : a study of 77 cases. Cancer 1983 ; 52:707-11.
14. Karakousis CP, Rao U, Moore R. Adrenal adenocarcinomas: histologic grading and survival. J Surg Oncol 1985 ; 29:105-11.
15. Van Slooten H, Moolenaar AJ, Van Seters AP, Smeenk D. The treatment of adrenocortical carcinoma with o,p'DDD: the prognosic implications of serum level-monitoring. Eur J Cancer Clin Oncol 1984 ; 20:47-53.
16. Haak HR, Hermans J, Van de Velde CJ, Lentjes EG, Gosling BM, Fleuren GJ. Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 1994 ; 69:947-51.
17. Robinson BG, Hales IB, Henniker AJ et al. The effect of o,p'-DDD on adrenal steroid replacement therapy requirements. Clin Endocrinol 1987 ; 27:437-44.
18. Thompson NW, Cheung PS. Diagnosis and treatment of functioning and nonfunctioning adrenocortical neoplasm including incidentalomas. Surg Clin North Am 1987 ; 67:423-36.
19. Kasperlik-Zalustra AA, Migdalska BM, Zgliczynsky S, Makowska AM. Adrenocortical carcinoma. A clinical study and treatment results of 52 patients. Cancer 1995 ; 75:2587-91.
20. Vassipoulou-Sellin R, Guinee V, Klein MJ et al. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer 1993 ; 71:3119-23.
21. Contreras P, Altieri E, Liberman C et al. Adrenal rest tumor of the liver causing Cushing's syndrome: treatment with ketoconazole preceding an apparent surgical cure. J Clin Endocrinol Metab 1985 ; 60:21-8.
22. Loli P, Berselli ME, Tagliaferri M. Use ketoconazole in the treatment of Cushing's syndrome. J Clin Endocrinol Metab 1986 ; 63:1365-71.
23. Sonino N, Boscaro M, Paolette A, Mantero F, Ziliotto D. Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin Endocrinol 1991 ; 35:347-52.
24. Sinnaeve LJE, Becks GP. Preoperative ketoconazole therapy for adrenocortical carcinoma. Can Med Assoc J 1989 ; 141:131-3.
25. Contreras P, Rojas A, Biagini L et al. Regression of metastatic adrenal carcinoma during palliative ketoconazole treatment. Lancet 1985 ; ii:151-2.
26. Trainer PJ, Besser M. Cushing's syndrome. Therapy directed at the adrenal glands. Endocrinol Metab Clin North Am 1994 ; 23:571-84.
27. Schteingart DE, Cash R, Conn JW. Aminoglutethimide and metastatic adrenal cancer: maintained reversal (six month) of Cushing's syndrome. JAMA 1966 ; 198:143-6.
28. Thoren M, Adamson U, Sjöberg HE. Aminoglutethimide and metyrapone in the management of Cushing's syndrome. Acta Endocrinol 1985 ; 109:451-7.
29. Verhelst JA, Trainer PJ, Howlett TA et al. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol 1991 ; 35:169-78.
30. Nieman LK, Chrousus GP, Kellner CH et al. Succesful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab 1985 ; 61:536-40.
31. Bates SE, Shieh CY, Micley LA et al. Mitotane enhances cytotoxicity of chimiotherapy in cell lines expressing a multidrug resistence gene (mdr-1/P glycoprotein) when is also expressed by adrenocortical carcinomas. J Clin Endocrinol Metab 1991 ; 73:18-29.
32. Chun HG, Yogoda A, Kemeny N. Cisplatinum for adrenal cortical carcinomas. Cancer Treat Rep 1983 ; 67:513-14.
33. Hesketh PJ, MC Caffrey RP, Finkel HE, Larmon SS, Griffing GT, Melby JC. Cisplatin based treatment of adrenocortical carcinoma. Cancer Treat Rep 1987 ; 71:222-4.
34. Burgess MA, Legha SS, Sellin RV. Chemotherapy with cisplatinum and etoposide (VP 16) for patients with advanced adrenal cortical carcinoma Proc ASCO. J Clin Oncol 1993 ; 12:188, abst.
35. Burowski RM, Wolfe M, Levine HS, Crawford DE, Stephens RL, Gaynor E et al. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma : a Southwest Oncology Group Study. J Clin Oncol 1993 ; 11:161-65.
36. Hag MM, Legha SS, Samaan NA, Bodey GP, Burges MA. Cytotoxic chemotherapy in adrenal cortical carcinoma. Cancer Treat Rep 1980 ; 64:909-913.
37. Decker PA, Elson P, Hogau TF, Citrin DL, Westring DW, Banerjee TK et al. Eastern Cooperative Oncology Group study 1879: mitotane and adriamycin in patients with advanced adrenocortical caranoma. Surgery 1991 ; 110:1006-13.
38. La Rocca RV, Stein CA, Danesi R, Tamis Dow CA, Weiss GH, Myers CE. Modulation of steroid hormone production, cytotoxicity in vitro and clinical antitumor effect. J Clin Endocrinol Metab 1990 ; 71:497.
39. Allolio B, Reincke M, Arlj W, Deuss U, Winkelmann W, Siekmann L. Suramin for treatment of adrenal carcinoma. Lancet 1989 ; i:277.
40. Van Slooten H, Van Osterom AT. CAP (cyclophosphamide, doxorubicin and cisplatin) regimen in adrenal cortical carcinoma. Cancer Treat Rep 1983 ; 67:377-9.
41. Schlumberger M, Brugières L, Gicquel C, Travagli JP, Droz JP, Parmentier C. 5 Fluorouracil, doxorubicin and cisplatin as treatment for adrenal cortical carcinoma. Cancer 1991 ; 67:2997-3000.
42. Johnson DH, Greco FA. Treatment of metastatic adrenal cortical carcinoma with asplatin and etoposide (VP 16). Cancer 1986 ; 58:2198-202.
43. Zidan J, Shpendler M, Robinson E. Treatment of metastatic adrenal cortical carcinoma with etoposide (VP 16) and cisplatin after failure with o.p'DDD. Am J Clin Oncol 1996 ; 19:229-31.
44. Grondal S, Cedemark B, Eriksson B et al. Adrenocortical carcinoma. A retrospective study of a rare tumor with a poor prognosis. Eur J Surg Oncol 1990 ; 16:500-6.
45. Percarpio B, Knowlton AH. Radiation therapy of adrenal cortical carcinoma. Acta Radiol Ther Phys Biol 1976 ; 15:288-92.
46. e eds. Perez CA, Brady LW eds. JB Lippincott, Philadelphia 1992 ; 1302-6.
47. Markoe AM, Serber W, Micaily B, Brady LW. Radiation therapy for adjunctive treatment of adrenal cortical carcinomas. Am J Clin Oncol 1991; 14:170-4.